CLINICAL CANCER RESEARCH是一本专注于临床癌症研究的国际期刊，ISSN号为1078-0432，由美国癌症研究协会（AACR）出版，每月出版两次，出版地为美国费城。该期刊为非开放获取（非OA）期刊，被SCI收录，2022年影响因子为11.5，在中科院分区中通常位于医学大类1区或2区。其发文特点集中于转化医学和临床癌症研究，涵盖肿瘤生物学、靶向治疗、免疫治疗、临床试验及癌症预防等领域，旨在推动基础研究成果向临床应用的转化。杂志以高质量和严格的同行评审著称，但投稿竞争激烈，拒稿率较高，对研究的创新性和临床相关性要求严格，适合发表具有重要临床意义的前沿研究。
Antibody–Drug Conjugates in Non–Small Cell Lung Cancer: Where Are the Target and the Biomarker?
2025-04-28T14:18:46Z
JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
2025-05-07T17:25:58Z
Emerging Strategies of Cell and Gene Therapy Targeting Tumor Immune Microenvironment
2025-04-10T14:01:00Z
Multimarker Assessment of B-Cell and Plasma Cell Subsets and Their Prognostic Role in the Colorectal Cancer Microenvironment
2025-04-08T16:56:44Z
Single-Cell Transcriptomic Landscape Deciphers Intratumoral Heterogeneity and Subtypes of Acral and Mucosal Melanomas
2025-04-07T15:01:24Z
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition With Quizartinib and Milademetan in <i>FLT3</i>-ITD Mutant/<i>TP53</i> Wild Type Acute Myeloid Leukemias
2025-05-06T15:21:50Z
Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-Grade Serous Tumors with Histologic Transformation
2025-05-06T15:23:58Z
Practical Considerations for Using the TITE-BOIN Design to Handle Late-onset Toxicity or Fast Accrual in Phase I Trials
2025-05-06T15:22:52Z
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better
2025-05-06T04:06:47Z
Effective TIL therapy for patients with checkpoint-resistant melanoma without lymphodepleting regimens requires interferon-alpha.
2025-05-06T15:23:47Z
Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions
2025-05-06T15:21:49Z
Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease
2025-04-17T13:57:01Z
Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression
2025-04-04T16:31:59Z
Targeting the MAP kinase pathway in colorectal cancer: A journey in personalized medicine
2025-05-01T14:19:14Z
Presurgical ablative radiation is associated with local control and immune response in pancreatic cancer
2025-05-01T14:44:19Z
Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the Phase II VISION study of tepotinib
2025-05-01T14:44:23Z
Safety and Tolerability of Lete-cel in NSCLC—Letter
2025-04-21T13:47:45Z
Safety and Tolerability of Lete-cel in NSCLC—Reply
2025-04-21T13:50:58Z
Nerve Types and Classification of Neurons Innervating Oral Cancer
2025-05-01T14:44:17Z
Metabolic Tumor Volume and Immunotherapy in NSCLC–Letter
2025-04-21T13:51:08Z
